Lactate Levels and Clearance: Key Predictors of Prognosis for COVID-19 and Non-COVID-19 Septic Shock Patients in the Emergency Department
-
Published:2024-05-09
Issue:3
Volume:14
Page:834-845
-
ISSN:2039-7283
-
Container-title:Clinics and Practice
-
language:en
-
Short-container-title:Clinics and Practice
Author:
Trebuian Cosmin Iosif1ORCID, Brici Octavia Maria2, Sutoi Dumitru1ORCID, Popa Daian Ionel2ORCID, Chioibas Daniel Raul1, Mederle Ovidiu Alexandru1ORCID
Affiliation:
1. Department of Surgery I, “Victor Babes” University of Medicine and Pharmacy, E. Murgu Square No. 2, 300041 Timisoara, Romania 2. Department of Doctoral Studies, “Victor Babes” University of Medicine and Pharmacy, E. Murgu Square No. 2, 300041 Timisoara, Romania
Abstract
Background: This investigation assesses the prognostic value of lactate levels and their clearance in septic shock patients, particularly emphasizing the comparative analysis between COVID-19 and non-COVID-19 patients in the emergency department. This study aims to elucidate the unique prognostic implications of lactate dynamics in these distinct patient groups, thereby enhancing the management of septic shock. Methods: An observational prospective study was conducted, enrolling 114 septic shock patients from the Emergency County Hospital Resita, Romania, categorizing them into COVID-19 and non-COVID-19 groups to examine their initial lactate levels, clearance rates, and their correlation with patient outcomes. Results: This study identified significant differences in the initial lactate levels and clearance rates between the two groups, indicating higher initial lactate levels and slower clearance rates in COVID-19 patients. Survivors demonstrated significantly lower initial lactate levels (1.5 ± 0.4 mmol/L) and higher lactate clearance rates (33 ± 15%) compared to non-survivors (2.5 ± 0.5 mmol/L and 24 ± 9%, respectively; lactate levels p = 0.001, clearance rates p = 0.002). Conclusions: Lactate monitoring, particularly clearance rates, is crucial in the prognostic assessment of septic shock patients. These findings highlight the need for targeted interventions in COVID-19 patients to improve outcomes, underscoring lactate dynamics as a vital component of septic shock management in differing patient populations.
Funder
VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY TIMISOARA
Reference37 articles.
1. Liu, J., Zhang, Q., Wong, Y.K., Luo, P., Chen, J., Xie, L., Chen, J., He, X., Shi, F., and Gong, P. (2024). Single-Cell Transcriptomics Reveals the Ameliorative Effect of Oridonin on Septic Liver Injury. Adv. Biol., 26. 2. Méndez, R., Figuerola, A., Ramasco, F., Chicot, M., Pascual, N.F., García, Í., von Wernitz, A., Zurita, N.D., Semiglia, A., and Pizarro, A. (2024). Decrease in Mortality after the Implementation of a Hospital Model to Improve Performance in Sepsis Care: Princess Sepsis Code. J. Pers. Med., 14. 3. Group of Biomedical Research in Critical Care Medicine (BioCritic) Epidemiological trends of sepsis in the twenty-first century (2000–2013): An analysis of incidence, mortality, and associated costs in Spain;Micheloud;Popul. Health Metr.,2018 4. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3);Singer;JAMA,2016 5. Incidence and mortality of hospital- and ICU-treated sepsis: Results from an updated and expanded systematic review and meta-analysis;Mellhammar;Intensive Care Med.,2020
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|